These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6544796)

  • 1. The antithrombotic effect of prostaglandin E1 immobilized on albuminated polymer matrix.
    Chandy T; Sharma CP
    J Biomed Mater Res; 1984; 18(9):1115-24. PubMed ID: 6544796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin immobilized albuminated surfaces.
    Joseph G; Sharma CP
    J Biomed Mater Res; 1987 Jul; 21(7):937-45. PubMed ID: 3301858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modification of polystyrene--platelet adhesion.
    Sharma CP; Hari PR
    J Biomater Appl; 1990 Jul; 5(1):49-55. PubMed ID: 2384862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials.
    Sagnella S; Mai-Ngam K
    Colloids Surf B Biointerfaces; 2005 May; 42(2):147-55. PubMed ID: 15833667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of synthetic and natural surfaces with blood in the physiological environment.
    Bruck SD
    J Biomed Mater Res; 1977 Jan; 11(1):1-21. PubMed ID: 845180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of platelet contact activation by prostaglandin E1 released from polyurethane surfaces.
    Lin JY; Okano T; Dost L; Feijen J; Kim SW
    Trans Am Soc Artif Intern Organs; 1985; 31():468-73. PubMed ID: 3837491
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective protein adsorption modulates platelet adhesion and activation to oligo(ethylene glycol)-terminated self-assembled monolayers with C18 ligands.
    Gonçalves IC; Martins MC; Barbosa MA; Naeemi E; Ratner BD
    J Biomed Mater Res A; 2009 Jun; 89(3):642-53. PubMed ID: 18442116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preparation of a urokinase-AT-III-PGE1-methyldopa complex, and its effects on platelet adhesion, coagulation times, protein adsorption, and fibrinolysis.
    Chandy T; Sharma CP
    Artif Organs; 1989 Jun; 13(3):229-37. PubMed ID: 2764762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombogenic surfaces: characterization and bioactivity of surface immobilized PGE1-heparin conjugate.
    Jacobs HA; Okano T; Kim SW
    J Biomed Mater Res; 1989 Jun; 23(6):611-30. PubMed ID: 2738078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility.
    Balakrishnan B; Kumar DS; Yoshida Y; Jayakrishnan A
    Biomaterials; 2005 Jun; 26(17):3495-502. PubMed ID: 15621239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved hemocompatibility of poly(ethylene terephthalate) modified with various thiol-containing groups.
    Gappa-Fahlenkamp H; Lewis RS
    Biomaterials; 2005 Jun; 26(17):3479-85. PubMed ID: 15621237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic effect of a new nitric oxide donor (LA419) on experimental thrombogenesis.
    Hernandez MR; Tonda R; Arderiu G; Pino M; Serradell M; Escolar G
    Eur J Clin Invest; 2005 May; 35(5):337-42. PubMed ID: 15860046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of antihypertensive drugs and steroid hormones on protein adsorption/desorption on polycarbonate.
    Chandy T; Sharma CP
    Artif Organs; 1991 Jun; 15(3):198-205. PubMed ID: 1867530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis.
    Li D; Chen H; Glenn McClung W; Brash JL
    Acta Biomater; 2009 Jul; 5(6):1864-71. PubMed ID: 19342321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-deposited tetraglyme surfaces greatly reduce total blood protein adsorption, contact activation, platelet adhesion, platelet procoagulant activity, and in vitro thrombus deposition.
    Cao L; Chang M; Lee CY; Castner DG; Sukavaneshvar S; Ratner BD; Horbett TA
    J Biomed Mater Res A; 2007 Jun; 81(4):827-37. PubMed ID: 17236214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.